Erasca, Inc. (ERAS)
13.26
-0.11
(-0.82%)
USD |
NASDAQ |
Jun 11, 10:57
Erasca Price : 13.26 for June 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 13.32 | 13.79 | 13.00 | 13.37 | 3.656M |
| Jun 09, 2026 | 13.22 | 13.44 | 12.26 | 13.41 | 4.651M |
| Jun 08, 2026 | 12.53 | 13.32 | 12.41 | 12.87 | 5.857M |
| Jun 05, 2026 | 13.08 | 13.27 | 11.80 | 11.97 | 6.144M |
| Jun 04, 2026 | 13.54 | 13.99 | 13.01 | 13.27 | 7.959M |
| Jun 03, 2026 | 13.57 | 13.74 | 12.71 | 13.18 | 4.624M |
| Jun 02, 2026 | 13.80 | 14.55 | 13.38 | 13.48 | 7.131M |
| Jun 01, 2026 | 13.21 | 15.03 | 12.86 | 13.82 | 10.52M |
| May 29, 2026 | 12.20 | 13.07 | 12.00 | 12.84 | 6.386M |
| May 28, 2026 | 12.57 | 12.70 | 12.10 | 12.20 | 4.054M |
| May 27, 2026 | 11.59 | 12.87 | 11.59 | 12.47 | 6.382M |
| May 26, 2026 | 11.36 | 11.58 | 10.93 | 11.50 | 3.187M |
| May 22, 2026 | 11.63 | 11.72 | 11.18 | 11.24 | 2.494M |
| May 21, 2026 | 11.10 | 11.75 | 10.97 | 11.60 | 3.110M |
| May 20, 2026 | 10.38 | 11.44 | 10.38 | 11.12 | 6.351M |
| May 19, 2026 | 10.37 | 10.78 | 10.07 | 10.32 | 4.021M |
| May 18, 2026 | 10.30 | 10.54 | 10.04 | 10.27 | 3.017M |
| May 15, 2026 | 10.16 | 10.32 | 9.95 | 10.23 | 3.334M |
| May 14, 2026 | 10.18 | 10.46 | 9.80 | 10.37 | 3.299M |
| May 13, 2026 | 10.28 | 10.62 | 9.87 | 10.46 | 4.340M |
| May 12, 2026 | 10.22 | 10.49 | 9.95 | 10.38 | 3.764M |
| May 11, 2026 | 10.50 | 10.69 | 10.10 | 10.44 | 3.804M |
| May 08, 2026 | 10.47 | 10.54 | 9.935 | 10.12 | 3.135M |
| May 07, 2026 | 10.81 | 10.88 | 10.00 | 10.40 | 4.972M |
| May 06, 2026 | 10.18 | 10.93 | 9.84 | 10.90 | 6.044M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Revolution Medicines, Inc. | 145.56 |
| Tango Therapeutics, Inc. | 28.29 |
| Kymera Therapeutics, Inc. | 80.62 |
| Bridgebio Oncology Therapeutics, Inc. | 7.42 |
| ImmunityBio, Inc. | 7.11 |
Price Related Metrics
| PEG Ratio | -0.2872 |
| Price to Book Value | 10.47 |
| Earnings Yield | -7.03% |
| Market Cap | 4.121B |
| PEGY Ratio | -0.2872 |